Robert Carey

President and Chief Operating Officer of Acelyrin, Inc.

Robert F. Carey has served as a member of Sangamo’s Board of Directors since June 2016. Mr. Carey currently serves as President and Chief Operating Officer of Acelyrin, Inc., a biopharmaceutical company focused on identifying, acquiring, and accelerating development and commercialization of promising drug candidates. Prior to Acelyrin, Mr. Carey served as executive vice president, chief business officer for Horizon Pharma plc from March 2014 to October 2019, and served as managing director and head of the healthcare investment banking group at JMP Securities LLC, a full-service investment bank, from March 2003 to March 2014. Previously, Mr. Carey was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities International, Inc., and held roles at Shearson Lehman Hutton and Ernst & Whinney. Mr. Carey also serves on the board of directors of Beyond Air, Inc. Mr. Carey received his B.S. in accounting from the University of Notre Dame.